BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 30039172)

  • 1. Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative.
    Mora S; Wenger NK; Cook NR; Liu J; Howard BV; Limacher MC; Liu S; Margolis KL; Martin LW; Paynter NP; Ridker PM; Robinson JG; Rossouw JE; Safford MM; Manson JE
    JAMA Intern Med; 2018 Sep; 178(9):1231-1240. PubMed ID: 30039172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study.
    Cook NR; Ridker PM
    JAMA Intern Med; 2014 Dec; 174(12):1964-71. PubMed ID: 25285455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
    Rana JS; Tabada GH; Solomon MD; Lo JC; Jaffe MG; Sung SH; Ballantyne CM; Go AS
    J Am Coll Cardiol; 2016 May; 67(18):2118-2130. PubMed ID: 27151343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.
    Vassy JL; Lu B; Ho YL; Galloway A; Raghavan S; Honerlaw J; Tarko L; Russo J; Qazi S; Orkaby AR; Tanukonda V; Djousse L; Gaziano JM; Gagnon DR; Cho K; Wilson PWF
    JAMA Netw Open; 2020 Jul; 3(7):e208236. PubMed ID: 32662843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
    JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Cataract Surgery With Mortality in Older Women: Findings from the Women's Health Initiative.
    Tseng VL; Chlebowski RT; Yu F; Cauley JA; Li W; Thomas F; Virnig BA; Coleman AL
    JAMA Ophthalmol; 2018 Jan; 136(1):3-10. PubMed ID: 29075781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.
    Muntner P; Colantonio LD; Cushman M; Goff DC; Howard G; Howard VJ; Kissela B; Levitan EB; Lloyd-Jones DM; Safford MM
    JAMA; 2014 Apr; 311(14):1406-15. PubMed ID: 24682252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Function and Cardiovascular Events in Postmenopausal Women: The Impact of Race and Ethnicity in the Women's Health Initiative.
    Arce CM; Rhee JJ; Cheung KL; Hedlin H; Kapphahn K; Franceschini N; Kalil RS; Martin LW; Qi L; Shara NM; Desai M; Stefanick ML; Winkelmayer WC;
    Am J Kidney Dis; 2016 Feb; 67(2):198-208. PubMed ID: 26337132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index.
    Khera R; Pandey A; Ayers CR; Carnethon MR; Greenland P; Ndumele CE; Nambi V; Seliger SL; Chaves PHM; Safford MM; Cushman M; Xanthakis V; Vasan RS; Mentz RJ; Correa A; Lloyd-Jones DM; Berry JD; de Lemos JA; Neeland IJ
    JAMA Netw Open; 2020 Oct; 3(10):e2023242. PubMed ID: 33119108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort.
    Emdin CA; Khera AV; Natarajan P; Klarin D; Baber U; Mehran R; Rader DJ; Fuster V; Kathiresan S
    Am J Cardiol; 2017 Mar; 119(6):881-885. PubMed ID: 28061997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary Artery Calcification (CAC) and Post-Trial Cardiovascular Events and Mortality Within the Women's Health Initiative (WHI) Estrogen-Alone Trial.
    Poornima IG; Mackey RH; Allison MA; Manson JE; Carr JJ; LaMonte MJ; Chang Y; Kuller LH;
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the American Heart Association/American College of Cardiology Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Self-reported Physical Activity Levels.
    Pandey A; Mehta A; Paluch A; Ning H; Carnethon MR; Allen NB; Michos ED; Berry JD; Lloyd-Jones DM; Wilkins JT
    JAMA Cardiol; 2021 Jun; 6(6):690-696. PubMed ID: 33909016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice.
    Medina-Inojosa JR; Somers VK; Garcia M; Thomas RJ; Allison T; Chaudry R; Wood-Wentz CM; Bailey KR; Mulvagh SL; Lopez-Jimenez F
    J Am Coll Cardiol; 2023 Oct; 82(15):1499-1508. PubMed ID: 37793746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies.
    Shapiro S
    Climacteric; 2006 Dec; 9(6):416-20. PubMed ID: 17085373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the American Heart Association cardiovascular disease prevention guideline for women.
    Hsia J; Rodabough RJ; Manson JE; Liu S; Freiberg MS; Graettinger W; Rosal MC; Cochrane B; Lloyd-Jones D; Robinson JG; Howard BV;
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):128-34. PubMed ID: 20160160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Medicare claims data to ascertain peripheral vascular events in the Women's Health Initiative.
    Mell MW; Pettinger M; Proulx-Burns L; Heckbert SR; Allison MA; Criqui MH; Hlatky MA; Burwen DR;
    J Vasc Surg; 2014 Jul; 60(1):98-105. PubMed ID: 24636641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is race or ethnicity associated with under-utilization of statins among women in the United States: The study of women's health across the nation.
    Jackson EA; Ruppert K; Derby CA; Lian Y; Chae CU; Kazlauskaite R; Neal-Perry G; El Khoudary SR; Harlow SD; Solomon DH
    Clin Cardiol; 2020 Dec; 43(12):1388-1397. PubMed ID: 32862481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of the US cholesterol guidelines on eligibility for statin therapy in the community: comparison of observed and predicted risks in the Framingham Heart Study Offspring Cohort.
    Andersson C; Enserro D; Larson MG; Xanthakis V; Vasan RS
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25888372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.
    Control Clin Trials; 1998 Feb; 19(1):61-109. PubMed ID: 9492970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.